Form 8-K - Current report:
SEC Accession No. 0001193125-24-262065
Filing Date
2024-11-20
Accepted
2024-11-20 06:04:30
Documents
14
Period of Report
2024-11-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d874287d8k.htm   iXBRL 8-K 40793
  Complete submission text file 0001193125-24-262065.txt   207435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241119.xsd EX-101.SCH 4467
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241119_def.xml EX-101.DEF 13883
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241119_lab.xml EX-101.LAB 23225
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241119_pre.xml EX-101.PRE 14852
17 EXTRACTED XBRL INSTANCE DOCUMENT d874287d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241478117
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)